Aviceda Therapeutics

Aviceda Therapeutics is a late-stage preclinical biotechnology company developing drugs for immune-mediated diseases. It focuses on deeply addressing the innate immune system and chronic non-lytic inflammation, specializing in next-generation immunomodulators. Aviceda is advancing immunotherapies targeting debilitating ocular and systemic degenerative diseases, oncology, fibrotic conditions, and immuno-inflammatory disorders.